Vice president of oncology clinical analysis at Lilly.
Related StoriesCrucial transformation in single DNA base predisposes children to aggressive type of cancerNew antenna-like gadget makes breast cancer medical procedures easier for surgeonsNew RNA test of blood platelets can be used to detect location of cancerPaul Bunn, M.D., Director of the University of Colorado Cancers Center said, I agree that Alimta should end up being available for individuals with lung tumor who are being treated in the second-collection setting. Based on its equivalent efficacy and superior side effect profile, Alimta is an improved alternative compared to the current regular of care, Taxotere. If approved by the FDA for treatment of second-line non-small cell lung cancer, Alimta would have two indications in the U.S.The American University of Doctors paper provides nine approaches that should be incorporated into a multifaceted medical liability reform initiative. Continued concentrate on individual prevention and safety of medical errors; Passage of a thorough tort reform bundle, including caps on non-economic damages; Minimum qualifications and requirements for expert witnesses; Oversight of medical liability insurers; Tests, and if warranted, growth of disclosure and communication programs; Pilot-testing a number of alternative dispute resolution models; Developing effective secure harbor protections that improve quality of care, increase efficiency, and reduce costs; Expanded testing of health courts and administrative compensation systems; Research into the effect of team-based care on medical liability, along with testing of enterprise liability and other items that protect and motivate team-based care.
AARP supports passing of healthcare reform Before the sun was in Idaho this morning up, families across the state buckling under soaring healthcare costs received a glimmer of hope from Washington, D.C.